Human and mouse homo-oligomeric meprin A metalloendopeptidase: substrate and inhibitor specificities

John E Bylander1, Greg P Bertenshaw, Gail L Matters

  • 1Department of Biochemistry and Molecular Biology, The Pennsylvania State University College of Medicine, Hershey, PA 17033-0850, USA.

Biological Chemistry
|November 3, 2007
PubMed

Insights

Comparing human and mouse meprin A reveals species-specific differences in structure, substrate preferences, and inhibitor responses. This research enhances the predictive value of mouse models for human diseases like diabetic nephropathy.

Area of Science:

  • Biochemistry
  • Enzymology
  • Proteomics

Background:

  • Meprin metalloproteinases are linked to diabetic nephropathy and inflammatory bowel diseases.
  • Meprins influence inflammatory responses and tissue damage in experimental models.

Purpose of the Study:

  • To compare human and mouse meprin A structure, substrates, and inhibitors.
  • To assess species-specific differences in meprin A function.

Main Methods:

  • Recombinant human and mouse meprin A were produced and characterized.
  • Enzyme activity was tested against various substrates (azocasein, fibronectin, collagen IV, peptides).
  • Inhibitor potencies (IC50) were determined for both species' meprin A.

Main Results:

  • Human meprin A forms larger oligomers than mouse meprin A.
  • Both enzymes show similar activity against many substrates, but differ in others (e.g., gelatin, secretin).
  • Human meprin A exhibits distinct P1' substrate preferences and variable inhibitor responses compared to mouse meprin A.

Conclusions:

  • Significant species-specific differences exist between human and mouse meprin A.
  • These findings improve the translational relevance of mouse models for human diseases involving meprins.
  • Understanding these differences is crucial for developing targeted therapies.